{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:22:16Z","timestamp":1761488536228},"reference-count":136,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T00:00:00Z","timestamp":1283212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Modifications to the treatment of acute lymphoblastic leukaemia (ALL) in children have led to a dramatic increase in survival in the past 40\u2003years. Despite this success, a significant subset of paediatric leukaemia patients either relapse or fail to ever achieve a complete remission. Additionally, some patients necessitate treatment with intensified chemotherapy regimens due to clinical or laboratory findings which identify them as high risk. These patients are unlikely to respond to further minor adjustments to the dosing or timing of administration of the same chemotherapy medications. Many novel targeted therapies for the treatment of childhood ALL provide potential mechanisms to further improve cure rates, and provide the possibility of minimizing toxicity to non\u2010malignant cells, given their specificity to malignant cell phenotypes. This article explores many of the potential targeted therapies in varying stages of development, from those currently in clinical trials to those still being refined in the research laboratory.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08282.x","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T21:31:47Z","timestamp":1283290307000},"page":"295-311","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development"],"prefix":"10.1111","volume":"151","author":[{"given":"Alisa B.","family":"Lee\u2010Sherick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel M. A.","family":"Linger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy K.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas K.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,31]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1361"},{"key":"e_1_2_9_3_1","first-page":"43","article-title":"Developmentally regulated expression of the novel cancer anti\u2010apoptosis gene survivin in human and mouse differentiation","volume":"152","author":"Adida C.","year":"1998","journal-title":"American Journal of Pathology"},{"key":"e_1_2_9_4_1","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1182\/blood.V80.11.2826.2826","article-title":"G19.4(alpha CD3) x B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen\u2010specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen\u2010positive cytotoxic T cells","volume":"80","author":"Anderson P.M.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22209"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2441"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6926"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-0929"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1892"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1939"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.7.2870.bloodjournal8772870"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400914"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc900128h"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-002824"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2436348100"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2498"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404277"},{"key":"e_1_2_9_18_1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1182\/blood.V81.4.1025.1025","article-title":"Prolonged survival of B\u2010lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl\u20102 protein","volume":"81","author":"Campana D.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3541203"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-1989"},{"key":"e_1_2_9_21_1","first-page":"2589","article-title":"The BCR\u2010ABL tyrosine kinase inhibits apoptosis by activating a Ras\u2010dependent signaling pathway","volume":"13","author":"Cortez D.","year":"1996","journal-title":"Oncogene"},{"key":"e_1_2_9_22_1","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1200\/jco.2006.24.18_suppl.6585","article-title":"A phase I clinical trial of the notch inhibitor MK\u20100752 in patients with T\u2010cell acute lymphoblastic leukemia\/lymphoma (T\u2010ALL) and other leukemias","volume":"24","author":"Deangelo D.J.","year":"2006","journal-title":"Journal of Clinical Oncology (Meeting Abstracts)"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404866"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0596-561"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.1031"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90111-B"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-2179"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1640"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2208"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-942273"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112086200"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb05853.x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4811-9_35"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0041"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-245944"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000153871.45184.19"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181bdf211"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204091"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-005-0135-z"},{"key":"e_1_2_9_40_1","unstructured":"Houghton P.J. Morton C.L. Maris J.M. Courtright J. Carol H. Lock R.B. Friedman H.S. Keir S.T. Gorlick R. Kolb E.A. Reynolds C.P. Kang M.&Smith M.A.(2008a)Pediatric preclinical testing program (PPTP) evaluation of the Aurora A kinase inhibitor MLN8237 [abstract]. In; Proceedings of the 99th Annual Meeting of the American Association for Cancer Research 2008 Apr 12\u201016: San Diego CA. AACR Philadelphia PA. Abstract 2997."},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21214"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403302"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4797"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1160"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2091"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3785"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23666"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-006-9000-0"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209633"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21988"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2193"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M105102200"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401705"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2006.06.009"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/325631a0"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-10-200305200-00010"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0104"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.1291"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.3885"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.2465"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/25141"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)00002-X"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209247"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21433"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<715::AID-IJC15>3.0.CO;2-P"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2443.2002.00592.x"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/379645a0"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfh254"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0811761106"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.469"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190902943077"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-219410"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3718"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.09.028"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2008.07.008"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0181"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606108103"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.5.2283"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-054098"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401129"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-242859"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.5.909"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602487"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80054-0"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.3528"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403253"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1900"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701344899"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0598"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205954"},{"key":"e_1_2_9_92_1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1182\/blood.V96.2.676.014k25_676_684","article-title":"Versatility of BCR\/ABL\u2010expressing leukemic cells in circumventing proapoptotic BAD effects","volume":"96","author":"Salomoni P.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.261"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1327"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.07.003"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1006\/smim.1998.0121"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)77164-0"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-005-0001-1"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00117-3"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.2514"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-117762"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3904"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099480"},{"key":"e_1_2_9_104_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi001603q"},{"key":"e_1_2_9_105_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1230693100"},{"key":"e_1_2_9_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-004-0947-2"},{"key":"e_1_2_9_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21508"},{"key":"e_1_2_9_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22188"},{"key":"e_1_2_9_109_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-091934"},{"key":"e_1_2_9_110_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.42.27084"},{"key":"e_1_2_9_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(05)81211-2"},{"key":"e_1_2_9_112_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-227660"},{"key":"e_1_2_9_113_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.2.680"},{"key":"e_1_2_9_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-008-9076-2"},{"key":"e_1_2_9_115_1","first-page":"5315","article-title":"IAP\u2010family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs","volume":"58","author":"Tamm I.","year":"1998","journal-title":"Cancer Research"},{"key":"e_1_2_9_116_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-137141"},{"key":"e_1_2_9_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.02.010"},{"key":"e_1_2_9_118_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10675"},{"key":"e_1_2_9_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2007.03.009"},{"key":"e_1_2_9_120_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200604032"},{"key":"e_1_2_9_121_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M801337200"},{"key":"e_1_2_9_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1524"},{"key":"e_1_2_9_123_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5383.1680"},{"key":"e_1_2_9_124_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2270"},{"key":"e_1_2_9_125_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1102160"},{"key":"e_1_2_9_126_1","first-page":"808","article-title":"Phase I trial of the farnesyltransferase inhibitor (FTI) R115777 in children with refractory leukemias","volume":"22","author":"Widemann B.C.","year":"2003","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"e_1_2_9_127_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612023393026"},{"key":"e_1_2_9_128_1","doi-asserted-by":"publisher","DOI":"10.1038\/310583a0"},{"key":"e_1_2_9_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90170-1"},{"key":"e_1_2_9_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.58"},{"key":"e_1_2_9_131_1","first-page":"4483","article-title":"FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction\u2010associated kinases","volume":"9","author":"Yao Q.","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_9_132_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911726107"},{"key":"e_1_2_9_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(92)90008-U"},{"key":"e_1_2_9_134_1","doi-asserted-by":"publisher","DOI":"10.1038\/2496"},{"key":"e_1_2_9_135_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0179"},{"key":"e_1_2_9_136_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.26.18141"},{"key":"e_1_2_9_137_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5426.418"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08282.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08282.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:11:15Z","timestamp":1697454675000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08282.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,31]]},"references-count":136,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08282.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08282.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,31]]},"assertion":[{"value":"2010-08-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}